BAGSVAERD, Denmark I March 29, 2025 I Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback